Population‐Based Study of Microinvasive Adenocarcinoma of the Uterine Cervix

Obstetrics and Gynecology

Volumn 97, Issue 5, 2001, Pages 701-706

  Webb, Joel C ^a   Key, Charles R ^a   Qualls, Clifford R ^a   Smith, Harriet O ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CANCER INVASION; CANCER STAGING; CONFIDENCE INTERVAL; FEMALE; HEALTH SURVEY; HUMAN; INCIDENCE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; METASTASIS; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; REGISTER; RISK FACTOR; SURVIVAL; UNITED STATES; UTERINE CERVIX TUMOR;

ADENOCARCINOMA; ADULT; AGED; ANALYSIS OF VARIANCE; CONFIDENCE INTERVALS; FEMALE; HUMANS; INCIDENCE; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEW MEXICO; POPULATION SURVEILLANCE; REGISTRIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 0035346924     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/00006250-200105000-00011     Document Type: Article

References (29)

1. Jones WB, Mercer GO, Lewis JL, Rubin SC, Hoskins WJ. Early invasive carcinoma of the cervix. Gynecol Oncol 1993;51:26-32.
2. Chen RJ, Chang DY, Yen ML, Lee EF, Huang SC, Chow SN, et al. Prognostic factors of primary adenocarcinoma of the uterine cervix. Gynecol Oncol 1998;69:157-64.
3. Photopulos GJ. Surgery or radiation for early cervical cancer. Clin Obstet Gynecol 1990;33:872-82.
4. Creasman WT. New gynecologic cancer staging. Gynecol Oncol 1995;58:157-8.
5. Creasman WT, Zaino RJ, Major FJ, DiSaia PJ, Hatch KD, Homesley HD. Early invasive carcinoma of the cervix (3 to 5 mm invasion): Risk factors and prognosis. Am J Obstet Gynecol 1998;178:62-5.
6. 1 cervical adenocarcinoma: Definition and treatment. Obstet Gynecol 1999;93:219-22.
7. Nicklin JL, Perrin LC, Crandon AJ, Ward BG. Microinvasive adenocarcinoma of the cervix. Aust N Z J Obstet Gynaecol 1999;39:411-3.
8. Kurian K, Al-Nafussi A. Relation of cervical glandular intraepithelial neoplasia to microinvasive and invasive adenocarcinoma of the uterine cervix: A study of 121 cases. J Clin Pathol 1999;52:112-7.
9. Ostor AG. Early invasive adenocarcinoma of the uterine cervix. Int J Gynecol Pathol 2000;19:29-38.
10. Covens A, Kirby J, Shaw P, Chapman W, Franseen E. Prognostic factors for relapse and pelvic lymph node metastases in early stage I adenocarcinoma of the cervix. Gynecol Oncol 1999;74:423-7.
11. Kaku T, Kamura T, Kunihiro S, Amada S, Kobayashi H, Shigematsu T, et al. Early adenocarcinoma of the uterine cervix. Gynecol Oncol 1997;65:281-5.
12. Kaspar HG, Dinh TV, Doherty MG, Hannigan EV, Kumar D. Clinical implications of tumor volume measurement in stage I adenocarcinoma of the cervix. Obstet Gynecol 1993;81:296-300.
13. Angel C, DuBeshter B, Lin JY. Clinical presentation and management of stage I cervical adenocarcinoma: A 25 year experience. Gynecol Oncol 1992;44:71-8.
14. Schorge JO, Lee KR, Sheets EE. Prospective management of stage IA(1) cervical adenocarcinoma by conization alone to preserve fertility: A preliminary report. Gynecol Oncol 2000;78:217-20.
15. Webb MJ. Radical hysterectomy. Baillieres Clin Obstet Gynaecol 1997;11:149-66.
16. Fu YS, Berek JS, Hilborne LH. Diagnostic problems of in situ and invasive adenocarcinomas of the uterine cervix. Appl Pathol 1987;5:47-56.
17. Brand E, Berek JS, Hacker NF. Controversies in the management of cervical adenocarcinoma. Obstet Gynecol 1988;71:261-9.
18. Berek JS, Hacker NF, Fu Y, Sokale JR, Leuchter RC, Lagasse LD. Adenocarcinoma of the uterine cervix: Histologic variables associated with lymph node metastasis and survival. Obstet Gynecol 1985;65:46-51.
19. McGonigle KF, Berek JS. Early-stage squamous cell and adenocarcinoma of the cervix. Curr Opin Obstet Gynecol 1992;4:109-19.
20. Smith HO, Tiffany MF, Qualls CR, Key CR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the U.S.—a 24 year population-based study. Gynecol Oncol 2000;78:97-105.
21. Surveillance, Epidemiology, and End Results SEER* Stat 3.0, Bethesda, Md, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, Cancer Statistics Branch, 2000.
22. Cunningham J, Ries L, Hankey B, Seiffert J, Lyles B, Shambaugh E, et al. The SEER program code manual, revised edition. National Institutes of Health Publication 92-1999. Washington, DC: US Government Printing Office, 1992.
23. Percy C, Van Holten V, Muir C, eds. International classification of diseases for oncology (ICD-O), 2nd edition. Geneva: World Health Organization, 1990.
24. International Classification of Diseases, 9th Revision. Department of Health and Human Services Publication #92-1260.
25. Teshima S, Shimosato Y, Kishi K, Kasamatsu T, Kazuo O, Uei Y. Early stage adenocarcinoma of the uterine cervix. Cancer 1985;56:167-72.
26. 1 adenocarcinoma of the cervix. Gynecol Oncol 2000;77:467-70.
27. Krivak TC, Retherford B, Voskuil S, Rose GS, Alagoz T. Recurrent invasive adenocarcinoma after hysterectomy for cervical adenocarcinoma in situ. Gynecol Oncol 2000;77:334-5.
28. Burghardt E. Microinvasive carcinoma in gynecological pathology. Clin Obstet Gynecol 1984;11:239-57.
29. Andersen ES, Arffmann E. Adenocarcinoma in situ of the uterine cervix: A clinico-pathologic study of 36 cases. Gynecol Oncol 1989;35:1-7.